Welcome to the August issue of The Highlight
GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have been wildly successful. But as popular as they are, Americans still have very negative feelings about the people using them. In this month’s Highlight cover story, Dylan Scott explains why ‘Ozempic stigma’ hasn’t gone away, how it’s impacting GLP-1 users, and whether it could begin to fade […]
In the August issue of The Highlight, Dylan Scott delves into the ongoing stigma surrounding GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. Despite their popularity, many Americans harbor negative sentiments towards those using these medications. Scott explores the impact of this stigma on users and discusses whether it may begin to subside as more individuals adopt these drugs.
Additionally, the issue covers strategies for tolerating uncertainty, the implications of rent freezes for renters, promising news about a decline in road fatalities, and the potential AI-led wealth boom. The August 4 issue will feature an article by Bryan Walsh titled "The Simple Idea That Helped Prevent Millions of Traffic Deaths," while Dylan Scott's "The One Thing Ozempic Still Can't Fix" will be published on the same day.
Elizabeth Weingarten's piece on "How to Tolerate Uncertainty in a World That's Full of It" is scheduled for August 5, and Marina Bolotnikova's examination of "The Truth About Rent Control" will also be released on that date. Sara Herschander's "The Rise of the AI-Aristocracy" will appear in the August 6 issue.
Written by urgent.news from Vox's reporting — not their text. Machine-written — it may contain errors, so check the original before relying on it.
![Google’s Pixel Tag picks a bold strategy in a sea of AirTag clones [Gallery]](/img/785857)
